Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowHematopoietic Stem Cell MobilizationGraft vs Host DiseaseHematopoietic Stem CellsBone Marrow CellsTransplantation ConditioningGranulocyte Colony-Stimulating FactorLeukapheresisStem CellsHematologic NeoplasmsAntigens, CD34Blood Component RemovalGraft SurvivalWhole-Body IrradiationCyclophosphamideBusulfanCombined Modality TherapyTissue DonorsMelphalanTransplantation ChimeraLeukemiaHematopoiesisStem Cell TransplantationAnemia, AplasticHistocompatibilityBone Marrow PurgingTreatment OutcomeHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsRecurrenceMultiple MyelomaBlood CellsLymphoma, Non-HodgkinBone and BonesCord Blood Stem Cell TransplantationRemission InductionTransplantation, IsogeneicBone Marrow DiseasesBlood Cell CountEtoposideLeukemia, Myeloid, AcuteImmunosuppressive AgentsTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsColony-Forming Units AssayLiver TransplantationThiotepaRetrospective StudiesAntineoplastic Agents, AlkylatingCytarabineCell DifferentiationLymphocyte DepletionDisease-Free SurvivalSurvival AnalysisFlow CytometryLeukocyte TransfusionT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaMice, Inbred C57BLSurvival RateInfectionLeukocyte CountMyelodysplastic SyndromesLeukemia, MyeloidCarmustinePlatelet CountAcute DiseaseHematologic DiseasesCell SeparationTransplantation ImmunologyCells, CulturedImmunophenotypingLymphomaHodgkin DiseaseImmunosuppressionSalvage TherapyHLA AntigensCyclosporineCytomegalovirus InfectionsRecombinant ProteinsBlood DonorsNuclear FamilyGraft vs Leukemia EffectAntigens, CDVincristineVidarabineRadiation ChimeraLymphocyte TransfusionFollow-Up StudiesKidney TransplantationGraft vs Tumor EffectGranulocytesIfosfamideLeukocytes, Mononuclear